← Open Payments lookup

THOMAS PEARCE: Open Payments

NPI 1053306589 · GLOUCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,107 in 46 payments from 18 companies in 2025. Trend: 2023 $2,909 · 2024 $2,011 · 2025 $1,107

Food & beverage: $1,107
CompanyPaymentsAmount
ABBVIE INC.7$147
Novo Nordisk Inc2$125
Novartis Pharmaceuticals Corporation4$108
Aimmune Therapeutics, Inc.5$103
Takeda Pharmaceuticals U.S.A., Inc.4$99
AstraZeneca Pharmaceuticals LP4$78
Bayer Healthcare Pharmaceuticals Inc.3$75
Amgen Inc.3$69
PFIZER INC.3$67
Teva Pharmaceuticals USA, Inc.2$54

Products named: Ozempic, LEQVIO, ZENPEP, TRINTELLIX, Kerendia, UBRELVY, PREVNAR 20, AUSTEDO XR.

Industry payments across MA — which companies pay providers there.